Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Engcan77on Jan 29, 2020 5:40pm

85 Views

Post# 30616568

RE:RE:RE:RE:RE:Maybe those "insiders" knew something?

It's been years and years of compensation and throwing around shares and options, with only one contract (well plus Wanbang from 6 years ago,that could take another few years to come to fruition) being signed in the last 10 years.
Yes,we have a lot going on right now, however nothing written in stone. Lets get on our feet first by making some cash, before handing out so many 'good job 'options to everyone and their dog.
Lets see all these promises from Howard happen in 2020. Then hopefully the continuing dilution of shares won't mean as much.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec